Genetic linkage of the human gene for phenylethanolamine N-methyltransferase (PNMT), the adrenaline-synthesizing enzyme, to DNA markers on chromosome 17q21-q22.
We have determined the genetic location of the human gene encoding phenylethanolamine N-methyltransferase (PNMT), the terminal enzyme of the catecholamine pathway catalyzing the synthesis of epinephrine (adrenaline) from norepinephrine. This gene is linked to DNA markers on the long arm of chromosome 17, q21-q22, most closely to the DNA markers MFD15 (D17S250) (Zmax = 15.0, theta = 0.065) and fLB17.1 (Zmax = 14.6, theta = 0.045). Multipoint linkage analysis placed the PNMT locus in the interval fLB17.1-CMM86 (D17S74), at 4 centiMorgans (cM) distal to fLB17.1, and at 17 cM proximal to CMM86. Mapping of the PNMT gene will provide the basis for genetic linkage studies in families with disease which might pathogenetically involve this enzyme. The human chromosomal region 17q21-22 identified here to harbour the PNMT gene may be syntenic to the chromosomal region in the stroke-prone spontaneously hypertensive rat (SHR-SP) recently linked to blood-pressure regulation. As an increase of PNMT activity has been associated with the development of hypertension in SHR-SP, it will be of interest to perform comparative mapping of the PNMT gene.
Hoehe
M R
MR
Clinical Neurogenetics Branch, National Institute of Mental Health, Bethesda, MD 20892.
Plaetke
R
R
Otterud
B
B
Stauffer
D
D
Holik
J
J
Byerley
W F
WF
Baetge
E E
EE
Gershon
E S
ES
Lalouel
J M
JM
Leppert
M
M
D000818:Animals; D002874:Chromosome Mapping; D002886:Chromosomes, Human, Pair 17; D004247:DNA / Q000235:genetics; D004837:Epinephrine / Q000096:biosynthesis; D008040:Genetic Linkage; D005819:Genetic Markers; D006801:Humans; D006973:Hypertension / Q000235:genetics; D010625:Phenylethanolamine N-Methyltransferase / Q000235:genetics*; D051381:Rats; D013045:Species Specificity
D005819:Genetic Markers; D004247:DNA; D010625:Phenylethanolamine N-Methyltransferase; D004837:Epinephrine